RE-33

• UNSPSC Description:

  RE-33 is an analgesic compound. RE-33 has blood brain barrier penetration ability[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/re-33.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(OC)OCN(C1=C2C)C([C@@](N3C(C4=C(N5N=CC=N5)C=CC(OC)=C4)=O)(CCC3)C)=NC1=CC=C2Cl

• Molecular Weight:

  538.98

• References & Citations:

  [1]Zhang Aiqin, et al. Condensed ring compound with analgesic activity and preparation method and application thereof. Patent. CN115925699.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2923520-98-1